Dennis Brown
Chairman at CELL SOURCE, INC.
Net worth: 84 170 $ as of 2024-03-30
Profile
Dennis M.
Brown is the founder of ChemGenex Therapeutics, Inc. (founded in 1999), Matrix Pharmaceutical, Inc. (founded in 1985), Kintara Therapeutics, Inc. (founded in 2009), ChemGenex Pharmaceuticals Pty Ltd.
(founded in 2004), Mountain View Pharmaceuticals, Inc. (founded in 2000), and Del Mar Pharmaceuticals (BC) Ltd.
(founded in 2010).
He is currently the Chairman of Cell Source, Inc. (since 2014), Director of Rakovina Therapeutics, Inc. (since 2021), Director of Azora Therapeutics, Inc., Director of Medasystems, Inc., Member-Research Roundtable of National Brain Tumor Society, Inc., and President of Valent Technologies LLC (since 2020).
He has previously worked as Managing Director at EGB Ventures LLC, Director at NewGen Therapeutics, Inc., Assistant Professor at Harvard Medical School, and Associate at Stanford University School of Medicine.
Dr. Brown's education includes an undergraduate degree from New York University (conferred in 1971) and graduate and doctorate degrees from New York University (conferred in 1975 and 1979 respectively).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-08-27 | 625,000 ( 0.96% ) | 41 250 $ | 2024-04-29 | |
CELL SOURCE, INC.
0.34% | 2023-07-31 | 129,929 ( 0.34% ) | 40 408 $ | 2024-03-30 |
CELL SOURCE, INC.
inf% | 2023-07-31 | 6,667 ( inf% ) | 2 073 $ | 2024-03-30 |
| 2024-05-15 | 2,776 ( 0.01% ) | 439 $ | 2024-04-29 |
Dennis Brown active positions
| Companies | Position | Start |
|---|---|---|
| CELL SOURCE, INC. | Chairman | 2015-08-18 |
| RAKOVINA THERAPEUTICS INC. | Director/Board Member | 2021-03-24 |
Medasystems, Inc.
 Medasystems, Inc. Packaged SoftwareTechnology Services Medasystems, Inc. is a software development company based in Menlo Park, CA. Medasystems specializes in developing software that streamlines the handling of requests for experimental therapies from healthcare providers. The company's secure and GXP compliant application acts as a centralized environment, connecting physicians and pharmaceutical companies to facilitate patient access to investigational therapies. The platform streamlines physician inquiries to life science companies for investigational medicine, including expanded access or compassionate use, post-trial access, and investigator-initiated studies. Medasystems provides pharmaceutical manufacturers with software and tools to streamline expanded access or compassionate use requests, as well as the evaluation of IIS or IST proposals, and the management of post-trial access. Medasystems, Inc. was founded by Jeffrey Thibeault, Matthew Rosen, and John Langlands. Fiona Smythe has been the CEO of the company since 2021. | Director/Board Member | - |
Azora Therapeutics, Inc.
 Azora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Azora Therapeutics, Inc. is a clinical stage biopharmaceutical company that develops novel small molecule chemical entities for the treatment of autoimmune and auto-inflammatory diseases. The company is based in Encino, CA. Azora Therapeutics was founded by Matthew Davidson and Julie Saiki, with Matthew Davidson serving as the CEO since incorporation. | Director/Board Member | - |
National Brain Tumor Society, Inc.
 National Brain Tumor Society, Inc. Miscellaneous Commercial ServicesCommercial Services National Brain Tumor Society, Inc. operates a foundation focused on brain tumor treatment. The company was founded by G. Bonnie Feldman in 2008 and is headquartered in Newton, MA. | Corporate Officer/Principal | - |
| Valent Technologies LLC | President | 2020-02-29 |
Mountain View Pharmaceuticals, Inc.
 Mountain View Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mountain View Pharmaceuticals, Inc. manufactures bio-pharmaceutical drugs. The American company was founded by Merry R. Sherman, Dennis M. Brown. Merry R. Sherman has been the CEO since incorporation. | Founder | 1999-12-31 |
Del Mar Pharmaceuticals (BC) Ltd.
 Del Mar Pharmaceuticals (BC) Ltd. Pharmaceuticals: MajorHealth Technology Part of Kintara Therapeutics, Inc., Del Mar Pharmaceuticals (BC) Ltd. provides drug development services. The company is based in Vancouver, Canada. The Canadian company was founded by William James Garner, Jeffrey A. Bacha, Dennis M. Brown. Jeffrey A. Bacha has been the CEO since incorporation. Del Mar Pharmaceuticals (BC was acquired by Kintara Therapeutics, Inc. on January 25, 2013 for $0.65 million. | Founder | 2010-04-01 |
Former positions of Dennis Brown
| Companies | Position | End |
|---|---|---|
| KINTARA THERAPEUTICS, INC. | Founder | 2023-11-19 |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
Training of Dennis Brown
| New York University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| CELL SOURCE, INC. | Health Technology |
| KINTARA THERAPEUTICS, INC. | Health Technology |
| RAKOVINA THERAPEUTICS INC. | Finance |
| Private companies | 11 |
|---|---|
EGB Ventures LLC
 EGB Ventures LLC Investment ManagersFinance EGB Ventures LLC EGB Ventures) is a venture capital firm founded in 2010 by William (Bill) Garner. The firm is headquartered in Whitewright, Texas. | Finance |
Del Mar Pharmaceuticals (BC) Ltd.
Del Mar Pharmaceuticals (BC) Ltd. Pharmaceuticals: MajorHealth Technology Part of Kintara Therapeutics, Inc., Del Mar Pharmaceuticals (BC) Ltd. provides drug development services. The company is based in Vancouver, Canada. The Canadian company was founded by William James Garner, Jeffrey A. Bacha, Dennis M. Brown. Jeffrey A. Bacha has been the CEO since incorporation. Del Mar Pharmaceuticals (BC was acquired by Kintara Therapeutics, Inc. on January 25, 2013 for $0.65 million. | Health Technology |
Mountain View Pharmaceuticals, Inc.
Mountain View Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mountain View Pharmaceuticals, Inc. manufactures bio-pharmaceutical drugs. The American company was founded by Merry R. Sherman, Dennis M. Brown. Merry R. Sherman has been the CEO since incorporation. | Health Technology |
| Valent Technologies LLC | |
ChemGenex Pharmaceuticals Pty Ltd.
 ChemGenex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology ChemGenex Pharmaceuticals Pty Ltd. develops pharmaceutical products. It develops small molecules with new mechanisms of action to treat malignancies with significant unmet medical needs. The firm also develops personalized oncology, obesity and diabetes medicines. The company was founded in September 1958 and is headquartered in Geelong, Australia. | Health Technology |
Matrix Pharmaceutical, Inc.
 Matrix Pharmaceutical, Inc. Medical SpecialtiesHealth Technology Matrix Pharmaceutical, Inc. is a company that researches and develops pharmaceutical products. The company is based in Fremont, CA. The company was founded in 1985 by Dennis M. Brown. Matrix Pharmaceutical was acquired by Chiron Corp. on February 19, 2002 for $58.63 million. | Health Technology |
| ChemGenex Therapeutics, Inc. | |
National Brain Tumor Society, Inc.
National Brain Tumor Society, Inc. Miscellaneous Commercial ServicesCommercial Services National Brain Tumor Society, Inc. operates a foundation focused on brain tumor treatment. The company was founded by G. Bonnie Feldman in 2008 and is headquartered in Newton, MA. | Commercial Services |
Azora Therapeutics, Inc.
Azora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Azora Therapeutics, Inc. is a clinical stage biopharmaceutical company that develops novel small molecule chemical entities for the treatment of autoimmune and auto-inflammatory diseases. The company is based in Encino, CA. Azora Therapeutics was founded by Matthew Davidson and Julie Saiki, with Matthew Davidson serving as the CEO since incorporation. | Health Technology |
Medasystems, Inc.
Medasystems, Inc. Packaged SoftwareTechnology Services Medasystems, Inc. is a software development company based in Menlo Park, CA. Medasystems specializes in developing software that streamlines the handling of requests for experimental therapies from healthcare providers. The company's secure and GXP compliant application acts as a centralized environment, connecting physicians and pharmaceutical companies to facilitate patient access to investigational therapies. The platform streamlines physician inquiries to life science companies for investigational medicine, including expanded access or compassionate use, post-trial access, and investigator-initiated studies. Medasystems provides pharmaceutical manufacturers with software and tools to streamline expanded access or compassionate use requests, as well as the evaluation of IIS or IST proposals, and the management of post-trial access. Medasystems, Inc. was founded by Jeffrey Thibeault, Matthew Rosen, and John Langlands. Fiona Smythe has been the CEO of the company since 2021. | Technology Services |
NewGen Therapeutics, Inc.
 NewGen Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology NewGen Therapeutics, Inc. engages in the provision of research and development services. The company is headquartered in Menlo Park, CA. | Health Technology |
- Stock Market
- Insiders
- Dennis Brown
